Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma

Publication Date: March 14, 2015

Last Updated: March 14, 2022

Recommendations for ASCT for HL

ASCT should not be offered as first-line therapy for advanced disease. (1+, A)

324799

Recommendations for Allo-HCT for HL

Allo-HCT should be used instead of conventional therapy for relapse after ASCT. (2++, B)

324799

Overview

Title

Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma

Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma

Recommendations for ASCT for HL

Recommendations for Allo-HCT for HL

Overview

Title

Authoring Organization